Researchers at Parabon NanoLabs have created a new way to develop and test medications that's more accurate and even faster than traditional drug development methods that rely on trial and error. The company first tested their new Parabon Essemblix Drug Development Platform on medicine to fight glioblastoma multiforme, a form of brain cancer. Using computer-aided design (CAD) software called inSēquio, scientists used a simple "drag-and-drop" interface to design a drug out of different molecules that can work together to find, latch onto, and attack cancer cells.
"In plug-and-play fashion, we can swap in or swap out any of the functional components."
After selecting the drug's features, researchers used a supercomputing platform that...
via The Verge - All Posts http://www.theverge.com/2012/12/24/3801102/3d-printing-and-self-assembling-dna-revolutionize-drug-development
No comments:
Post a Comment